hims glp 1 results Last week, and Hers announced an oral GLP-1 pill., Days later, it was gone., FDA approval exists for a reason., Marketing isn’t evidence., Would you trust this company with your health?, Hims & Hers to offer
Description
patent law allowing excessive extensions that delay generics from entering the market

Unlike the body's natural GLP-1, which breaks down within minutes, these medications are designed to remain active for much longerranging from once-daily to once-weekly formulations
Gilead Chairman and CEO Daniel ODay called Livdelzi an important new option for patients and doctors, adding, People living with PBC [primary biliary cholangitis] have been waiting for treatment advancements for many years. Livdelzis approval is supported by the Phase III RESPONSE trial, in which treatment with the drug elicited a significantly higher rate of composite biochemical response

The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician
